Meijing Wu

CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells

Alan L. Chang, Jason Miska, Derek A. Wainwright et al. · Cancer Research · 2016 · 620 citations · Full text

Medicine, Immunology, Oncology +17

Mutant IDH1 and seizures in patients with glioma

Hao Chen, Jonathon Judkins, Cheddhi Thomas et al. · Neurology · 2017 · 260 citations · Full text

Life Sciences, Neuroscience, Oncology +14

Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient Survival

Lijie Zhai, Erik Ladomersky, Kristen L. Lauing et al. · Clinical Cancer Research · 2017 · 177 citations · Full text

Medicine, Cancer Biology, Oncology +17

Mutant IDH1 and thrombosis in gliomas

Dusten Unruh, Steven R. Schwarze, Laith Khoury et al. · Acta Neuropathologica · 2016 · 175 citations · Full text

Medicine, Molecular Genetics, Oncology +12

Cell-Penetrating Peptide-Modified Gold Nanoparticles for the Delivery of Doxorubicin to Brain Metastatic Breast Cancer

Ramin A. Morshed, Megan E. Muroski, Qing Dai et al. · Molecular Pharmaceutics · 2016 · 125 citations

Pharmacy, Oncology, Pharmaceutics +17